SCHEMBL967673

SCHEMBL967673

CCN(C(=O)O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6251081 0.81
SCHEMBL9435691 0.79
SCHEMBL967292 0.79 PGR (0.31)
SCHEMBL3535872 0.79 MEN1 (0.34)
SCHEMBL10976057 0.79
SCHEMBL6207217 0.79 MEN1 (0.38)
SCHEMBL967670 0.78
SCHEMBL497965 0.78
SCHEMBL8593198 0.78
SCHEMBL23000662 0.77 PGR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN claimed
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 EP claimed
US-5017636-A Also containing polyisoprene, natural rubber, butadiene-styrene copolymer, wear and heat resistance, resilience JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-05-21 US claimed
CN-117986215-A 2-Phenyl-4-acyl benzofurans, preparation and application thereof 中国医学科学院药物研究所 2024-05-07 CN disclosed
US-20230338565-A1 ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2023-10-26 US disclosed
EP-4151235-A1 ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2023-03-22 EP disclosed
CN-114025844-B Protein tyrosine phosphatase inhibitors and methods of use thereof 卡里科生命科学有限责任公司 2022-07-26 CN disclosed
CN-113226377-A Antibody drug conjugates comprising an eltrinastine derivative 法马马有限公司 2021-08-06 CN disclosed
EP-2943474-B1 BIARYL- OR HETEROCYCLIC BIARYL-SUBSTITUTED CYCLOHEXENE DERIVATIVE COMPOUNDS AS CETP INHIBITORS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2017-07-05 EP disclosed
US-9583791-B2 Electrolytic solution and battery SONY CORPORATION (JP) 2017-02-28 US disclosed
US-8679683-B2 Electrolyte solution containing a cyclic imide salt and light metal salt and battery SONY CORPORATION (JP) 2014-03-25 US disclosed
US-20100016612-A1 FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME, AND FLUORINE-CONTAINING PYRAZOLECARBOXYLIC ACID DERIVATIVE OBTAINED BY USING THE FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME MITSUI CHEMICALS AGRO, INC (JP) 2010-01-21 US disclosed
EP-2128139-A1 FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME, AND FLUORINE-CONTAINING PYRAZOLECARBOXYLIC ACID DERIVATIVE OBTAINED BY USING THE FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-02 EP disclosed
US-20080193854-A1 Cyclic imide salt of 1,1,2,2,3,3-hexafluoropropane-1,3-disulfonimide lithium and a light metal salt of difluoro[oxalato-O,O'] lithium borate or bis[oxalato-O,O'] lithium borate SONY CORPORATION (JP) 2008-08-14 US disclosed
US-20060228626-A1 ELECTROLYTIC SOLUTION AND BATTERY TOHOKU MURATA MANUFACTURING CO.,LTD (JP) 2006-10-12 US disclosed
EP-1590358-A1 9-KETOSPINOSYN DERIVATIVES Bayer CropScience Aktiengesellschaft (DE) 2005-11-02 EP disclosed
US-20040218347-A1 Flame-retardant electrolyte solution for electrochemical double-layer capacitors EPCOS AG (DE) 2004-11-04 US disclosed
WO-2004065402-A1 9-KETOSPINOSYN DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2004-08-05 WO disclosed
US-5302711-A Ester cleavage process for use with β-lactams ELI LILLY AND COMPANY (US) 1994-04-12 US disclosed
EP-0557035-A2 An ester cleavage process for use with beta-lactams ELI LILLY AND COMPANY (US) 1993-08-25 EP disclosed